Glioma Stem Cells: Signaling, Microenvironment, and Therapy
Glioblastoma remains the most common and devastating primary brain tumor despite maximal therapy with surgery, chemotherapy, and radiation. The glioma stem cell (GSC) subpopulation has been identified in glioblastoma and likely plays a key role in resistance of these tumors to conventional therapies...
Saved in:
Main Authors: | Brandon D. Liebelt, Takashi Shingu, Xin Zhou, Jiangong Ren, Seul A. Shin, Jian Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/7849890 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
by: Dong-Sup Chung, et al.
Published: (2014-01-01) -
The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials
by: Seidu A. Richard, et al.
Published: (2021-01-01) -
Stem Cells: Microenvironment, Micro/Nanotechnology, and Application
by: Hua Liu, et al.
Published: (2015-01-01) -
Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
by: Zhengyuan Huo, et al.
Published: (2024-01-01) -
V-ATPase in glioma stem cells: a novel metabolic vulnerability
by: Alessandra Maria Storaci, et al.
Published: (2025-01-01)